[DOI] [PubMed] [Google Scholar] 105.Lermant A., Murdoch C.E
Description CJC-1295 + Ipamorelin | 99%+ Pure Peptide Blend Advance growth-hormone (GH) axis research with a dual-pathway blend that pairs a long-acting GHRH analogue (CJC-1295) with a selective GHSR (ghrelin) agonist (Ipamorelin)
The peptides short half-life of 4-6 hours means twice-daily dosing produces more consistent tissue levels than single daily administration
Elo IT, Luck A, Stokes AC, Hempstead K, Xie W, Preston SH
Yang R, Walder-Christensen KK, Kim N, Wu D, Lorenzo DN, Badea A, et al
The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV